Shijie Li
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Renal and related cancers
- Circular RNAs in diseases
Papers in
-
- Renal and related cancers 2
- Circular RNAs in diseases 2
- DNA Repair Mechanisms 1
- Surgery 7
- Bladder and Urothelial Cancer Treatments 6
- Co-authors
- Xiaonan Chen (14 shared papers)Kefeng Wang (4 shared papers)Zhenqun Xu (6 shared papers)Linzhao Cheng (1 shared paper)Jianyi Zheng (7 shared papers)James C. Mullikin (1 shared paper)Nancy F. Hansen (1 shared paper)Peiqing Liu (1 shared paper)
- Journals
- Theriogenology (2 papers)Cancer Medicine (2 papers)Biomedicine & Pharmacotherapy (2 papers)Oncology Reports (1 paper)Cancer Cell International (1 paper)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Shijie Li
24 papers receiving 518 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 124
- Molecular Biology 302
- Reproductive Medicine 34
- Immunology 50
- Oncology 54
Countries citing papers authored by Shijie Li
This map shows the geographic impact of Shijie Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijie Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijie Li more than expected).
Fields of papers citing papers by Shijie Li
This network shows the impact of papers produced by Shijie Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijie Li. The network helps show where Shijie Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Shijie Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 190 | |
| 2 | 2014 | 54 | |
| 3 | 2023 | 50 | |
| 4 | 2006 | 45 | |
| 5 | 2015 | 26 | |
| 6 | 2023 | 22 | |
| 7 | 2016 | 18 | |
| 8 | 2021 | 16 | |
| 9 | 2023 | 14 | |
| 10 | 2024 | 12 | |
| 11 | 2021 | 10 | |
| 12 | 2022 | 10 | |
| 13 | 2001 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2023 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2022 | 6 | |
| 18 | 2021 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Shijie Li
Shijie Li is a scholar working on Molecular Biology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 24 papers that have together received 525 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (3 papers), Cancer Genomics and Diagnostics (2 papers), Renal and related cancers (2 papers), Circular RNAs in diseases (2 papers), Reproductive System and Pregnancy (2 papers), Advanced Proteomics Techniques and Applications (1 paper) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Cancer Research (124 citations), Molecular Biology (302 citations), Reproductive Medicine (34 citations), Immunology (50 citations) and Oncology (54 citations). Shijie Li has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Xiaonan Chen, Kefeng Wang, Zhenqun Xu, Linzhao Cheng, Jianyi Zheng, James C. Mullikin, Nancy F. Hansen, Peiqing Liu, Frank X. Donovan and Settara C. Chandrasekharappa. Their work appears in journals such as Theriogenology, Cancer Medicine, Biomedicine & Pharmacotherapy, Oncology Reports and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.